Wnt-regulated lncRNA discovery enhanced by in vivo identification and CRISPRi functional validation.

Abstract:

BACKGROUND:Wnt signaling is an evolutionarily conserved developmental pathway that is frequently hyperactivated in cancer. While multiple protein-coding genes regulated by Wnt signaling are known, the functional lncRNAs regulated by Wnt signaling have not been systematically characterized. METHODS:We comprehensively mapped Wnt-regulated lncRNAs from an orthotopic Wnt-addicted pancreatic cancer model and examined the response of lncRNAs to Wnt inhibition between in vivo and in vitro cancer models. We further annotated and characterized these Wnt-regulated lncRNAs using existing genomic classifications (using data from FANTOM5) in the context of Wnt signaling and inferred their role in cancer pathogenesis (using GWAS and expression data from the TCGA). To functionally validate Wnt-regulated lncRNAs, we performed CRISPRi screens to assess their role in cancer cell proliferation both in vivo and in vitro. RESULTS:We identified 3633 lncRNAs, of which 1503 were regulated by Wnt signaling in an orthotopic Wnt-addicted pancreatic cancer model. These lncRNAs were much more sensitive to changes in Wnt signaling in xenografts than in cultured cells. Our analysis suggested that Wnt signaling inhibition could influence the co-expression relationship of Wnt-regulated lncRNAs and their eQTL-linked protein-coding genes. Wnt-regulated lncRNAs were also implicated in specific gene networks involved in distinct biological processes that contribute to the pathogenesis of cancers. Consistent with previous genome-wide lncRNA CRISPRi screens, around 1% (13/1503) of the Wnt-regulated lncRNAs were found to modify cancer cell growth in vitro. This included CCAT1 and LINC00263, previously reported to regulate cancer growth. Using an in vivo CRISPRi screen, we doubled the discovery rate, identifying twice as many Wnt-regulated lncRNAs (25/1503) that had a functional effect on cancer cell growth. CONCLUSIONS:Our study demonstrates the value of studying lncRNA functions in vivo, provides a valuable resource of lncRNAs regulated by Wnt signaling, and establishes a framework for systematic discovery of functional lncRNAs.

journal_name

Genome Med

journal_title

Genome medicine

authors

Liu S,Harmston N,Glaser TL,Wong Y,Zhong Z,Madan B,Virshup DM,Petretto E

doi

10.1186/s13073-020-00788-5

subject

Has Abstract

pub_date

2020-10-22 00:00:00

pages

89

issue

1

issn

1756-994X

pii

10.1186/s13073-020-00788-5

journal_volume

12

pub_type

杂志文章
  • Creating a data resource: what will it take to build a medical information commons?

    abstract::National and international public-private partnerships, consortia, and government initiatives are underway to collect and share genomic, personal, and healthcare data on a massive scale. Ideally, these efforts will contribute to the creation of a medical information commons (MIC), a comprehensive data resource that is...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-017-0476-3

    authors: Deverka PA,Majumder MA,Villanueva AG,Anderson M,Bakker AC,Bardill J,Boerwinkle E,Bubela T,Evans BJ,Garrison NA,Gibbs RA,Gentleman R,Glazer D,Goldstein MM,Greely H,Harris C,Knoppers BM,Koenig BA,Kohane IS,La Rosa S,

    更新日期:2017-09-22 00:00:00

  • Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis.

    abstract:BACKGROUND:Imiquimod (IMQ) produces a cutaneous phenotype in mice frequently studied as an acute model of human psoriasis. Whether this phenotype depends on strain or sex has never been systematically investigated on a large scale. Such effects, however, could lead to conflicts among studies, while further impacting st...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-017-0415-3

    authors: Swindell WR,Michaels KA,Sutter AJ,Diaconu D,Fritz Y,Xing X,Sarkar MK,Liang Y,Tsoi A,Gudjonsson JE,Ward NL

    更新日期:2017-03-09 00:00:00

  • Allele-specific expression in the human heart and its application to postoperative atrial fibrillation and myocardial ischemia.

    abstract:BACKGROUND:Allele-specific expression (ASE) is differential expression of each of the two chromosomal alleles of an autosomal gene. We assessed ASE patterns in the human left atrium (LA, n = 62) and paired samples from the left ventricle (LV, n = 76) before and after ischemia, and tested the utility of differential ASE...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-016-0381-1

    authors: Sigurdsson MI,Saddic L,Heydarpour M,Chang TW,Shekar P,Aranki S,Couper GS,Shernan SK,Seidman JG,Body SC,Muehlschlegel JD

    更新日期:2016-12-06 00:00:00

  • Genome-wide approaches for identifying genetic risk factors for osteoporosis.

    abstract::Osteoporosis, the most common type of bone disease worldwide, is clinically characterized by low bone mineral density (BMD) and increased susceptibility to fracture. Multiple genetic and environmental factors and gene-environment interactions have been implicated in its pathogenesis. Osteoporosis has strong genetic de...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/gm448

    authors: Wu S,Liu Y,Zhang L,Han Y,Lin Y,Deng HW

    更新日期:2013-05-29 00:00:00

  • Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer.

    abstract:BACKGROUND:Based on promising phase II data, the histone deacetylase inhibitor entinostat is in phase III trials for patients with metastatic estrogen receptor-positive breast cancer. Predictors of sensitivity and resistance, however, remain unknown. METHODS:A total of eight cell lines and nine mouse models of breast ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-018-0597-3

    authors: Tanioka M,Mott KR,Hollern DP,Fan C,Darr DB,Perou CM

    更新日期:2018-11-30 00:00:00

  • Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies.

    abstract:BACKGROUND:The advent of personalized medicine requires robust, reproducible biomarkers that indicate which treatment will maximize therapeutic benefit while minimizing side effects and costs. Numerous molecular signatures have been developed over the past decade to fill this need, but their validation and up-take into...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm385

    authors: Starmans MH,Pintilie M,John T,Der SD,Shepherd FA,Jurisica I,Lambin P,Tsao MS,Boutros PC

    更新日期:2012-11-12 00:00:00

  • Ultradeep analysis of tumor heterogeneity in regions of somatic hypermutation.

    abstract::Tumor heterogeneity is of growing importance in the treatment of cancers. Mutational hot spots are prime locations for determining number and proportions of low variant allele frequency (VAF) tumor subclones by next generation sequencing. Low VAF detection is complicated by poor mapping efficiency in regions with high...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0147-1

    authors: Spence JM,Spence JP,Abumoussa A,Burack WR

    更新日期:2015-03-12 00:00:00

  • Linking genes to diseases: it's all in the data.

    abstract::Genome-wide association analyses on large patient cohorts are generating large sets of candidate disease genes. This is coupled with the availability of ever-increasing genomic databases and a rapidly expanding repository of biomedical literature. Computational approaches to disease-gene association attempt to harness...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm77

    authors: Tiffin N,Andrade-Navarro MA,Perez-Iratxeta C

    更新日期:2009-08-07 00:00:00

  • The three-body problem of therapy with induced pluripotent stem cells.

    abstract::Regenerative medicine has a three-body problem: alignment of the dynamics of the genome, stem cell and patient. Focusing on the rare inherited fragile skin disorder epidermolysis bullosa, three recent innovative studies have used induced pluripotent stem cells and gene correction, revertant mosaicism or genome editing...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0141-7

    authors: Tolar J,McGrath JA

    更新日期:2015-02-20 00:00:00

  • Pancreatic cancer genomics: insights and opportunities for clinical translation.

    abstract::Pancreatic cancer is a highly lethal tumor type for which there are few viable therapeutic options. It is also caused by the accumulation of mutations in a variety of genes. These genetic alterations can be grouped into those that accumulate during pancreatic intraepithelial neoplasia (precursor lesions) and thus are ...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/gm430

    authors: Makohon-Moore A,Brosnan JA,Iacobuzio-Donahue CA

    更新日期:2013-03-28 00:00:00

  • Consensus: a framework for evaluation of uncertain gene variants in laboratory test reporting.

    abstract::Accurate interpretation of gene testing is a key component in customizing patient therapy. Where confirming evidence for a gene variant is lacking, computational prediction may be employed. A standardized framework, however, does not yet exist for quantitative evaluation of disease association for uncertain or novel g...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm347

    authors: Crockett DK,Ridge PG,Wilson AR,Lyon E,Williams MS,Narus SP,Facelli JC,Mitchell JA

    更新日期:2012-05-28 00:00:00

  • A population-based gene expression signature of molecular clock phase from a single epidermal sample.

    abstract:BACKGROUND:For circadian medicine to influence health, such as when to take a drug or undergo a procedure, a biomarker of molecular clock phase is required--one that is easily measured and generalizable across a broad population. It is not clear that any circadian biomarker yet satisfies these criteria. METHODS:We ana...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00768-9

    authors: Wu G,Ruben MD,Francey LJ,Smith DF,Sherrill JD,Oblong JE,Mills KJ,Hogenesch JB

    更新日期:2020-08-21 00:00:00

  • Hematopoietic stem cells, hematopoiesis and disease: lessons from the zebrafish model.

    abstract::The zebrafish model is rapidly gaining prominence in the study of development, hematopoiesis, and disease. The zebrafish provides distinct advantages over other vertebrate models during early embryonic development by producing transparent, externally fertilized embryos. Embryonic zebrafish are easily visualized and ma...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm299

    authors: Martin CS,Moriyama A,Zon LI

    更新日期:2011-12-29 00:00:00

  • Use of semantic workflows to enhance transparency and reproducibility in clinical omics.

    abstract:BACKGROUND:Recent highly publicized cases of premature patient assignment into clinical trials, resulting from non-reproducible omics analyses, have prompted many to call for a more thorough examination of translational omics and highlighted the critical need for transparency and reproducibility to ensure patient safet...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0202-y

    authors: Zheng CL,Ratnakar V,Gil Y,McWeeney SK

    更新日期:2015-07-25 00:00:00

  • NARD: whole-genome reference panel of 1779 Northeast Asians improves imputation accuracy of rare and low-frequency variants.

    abstract::Here, we present the Northeast Asian Reference Database (NARD), including whole-genome sequencing data of 1779 individuals from Korea, Mongolia, Japan, China, and Hong Kong. NARD provides the genetic diversity of Korean (n = 850) and Mongolian (n = 384) ancestries that were not present in the 1000 Genomes Project Phas...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-019-0677-z

    authors: Yoo SK,Kim CU,Kim HL,Kim S,Shin JY,Kim N,Yang JSW,Lo KW,Cho B,Matsuda F,Schuster SC,Kim C,Kim JI,Seo JS

    更新日期:2019-10-22 00:00:00

  • Systems and genome-wide approaches unite to provide a route to personalized medicine.

    abstract::A report on the Keystone Symposium 'Complex Traits: Genomics and Computational approaches', Breckenridge, Colorado, USA, 20-25 February 2012. ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm328

    authors: Stranger BE,Björkegren J,Dolan ME,Ritchie MD

    更新日期:2012-03-30 00:00:00

  • Personalizing carbamazepine therapy.

    abstract::The anticonvulsant carbamazepine has a high incidence of cutaneous adverse drug reactions. A recent prospective clinical trial in Taiwan has indicated that HLA-B*1502 screening will reduce the incidence of life-threatening adverse reactions to carbamazepine, while a genome-wide association study has identified the HLA...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm243

    authors: Mushiroda T,Nakamura Y

    更新日期:2011-05-30 00:00:00

  • PPAR action in insulin resistance unraveled by metabolomics: potential clinical implications.

    abstract::Metabolomic analysis will provide the next large set of clues to further our understanding of human health and disease. A recent study has elucidated the significant differences in the metabolomes of adipocytes, serum and an adipocyte cell line after activation of two nuclear receptors, peroxisome proliferator activat...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm270

    authors: Patterson AD,Peters JM

    更新日期:2011-08-23 00:00:00

  • An epigenome-wide association study of sex-specific chronological ageing.

    abstract:BACKGROUND:Advanced age is associated with cognitive and physical decline and is a major risk factor for a multitude of disorders. There is also a gap in life expectancy between males and females. DNA methylation differences have been shown to be associated with both age and sex. Here, we investigate age-by-sex differe...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-019-0693-z

    authors: McCartney DL,Zhang F,Hillary RF,Zhang Q,Stevenson AJ,Walker RM,Bermingham ML,Boutin T,Morris SW,Campbell A,Murray AD,Whalley HC,Porteous DJ,Hayward C,Evans KL,Chandra T,Deary IJ,McIntosh AM,Yang J,Visscher PM,McRa

    更新日期:2019-12-31 00:00:00

  • Mode and dynamics of vanA-type vancomycin resistance dissemination in Dutch hospitals.

    abstract:BACKGROUND:Enterococcus faecium is a commensal of the gastrointestinal tract of animals and humans but also a causative agent of hospital-acquired infections. Resistance against glycopeptides and to vancomycin has motivated the inclusion of E. faecium in the WHO global priority list. Vancomycin resistance can be confer...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00825-3

    authors: Arredondo-Alonso S,Top J,Corander J,Willems RJL,Schürch AC

    更新日期:2021-01-20 00:00:00

  • Genome-wide association studies are coming for human infectious diseases.

    abstract::A genetic contribution to infectious disease in human populations has long been suspected and is now supported by more than 50 years of epidemiological evidence showing, for example, infection rates to be much higher than disease rates. In successful family studies of high-penetrance effects, single gene mutations hav...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm19

    authors: Davila S,Hibberd ML

    更新日期:2009-02-10 00:00:00

  • Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.

    abstract:BACKGROUND:Chemotherapeutic agents such as anthracyclines and taxanes are commonly used in the neoadjuvant setting. Bevacizumab is an antibody which binds to vascular endothelial growth factor A (VEGFA) and inhibits its receptor interaction, thus obstructing the formation of new blood vessels. METHODS:A phase II rando...

    journal_title:Genome medicine

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/s13073-018-0601-y

    authors: Höglander EK,Nord S,Wedge DC,Lingjærde OC,Silwal-Pandit L,Gythfeldt HV,Vollan HKM,Fleischer T,Krohn M,Schlitchting E,Borgen E,Garred Ø,Holmen MM,Wist E,Naume B,Van Loo P,Børresen-Dale AL,Engebraaten O,Kristensen V

    更新日期:2018-11-29 00:00:00

  • Sharing knowledge: a new frontier for public-private partnerships in medicine.

    abstract::To help overcome the bottlenecks that limit the development of diagnostic and therapeutic products, academic and industrial researchers, patient organizations and charities, and regulatory and funding institutions should redefine the basis for sharing the knowledge collected in large-scale clinical and experimental st...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm29

    authors: Auffray C

    更新日期:2009-03-04 00:00:00

  • High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.

    abstract:BACKGROUND:Neisseria meningitidis is a globally important cause of meningitis and septicaemia. Twelve capsular groups of meningococci are known, and quadrivalent vaccines against four of these (A, C, W and Y) are available as plain-polysaccharide and protein-polysaccharide conjugate vaccines. Here we apply contemporary...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-017-0400-x

    authors: O'Connor D,Clutterbuck EA,Thompson AJ,Snape MD,Ramasamy MN,Kelly DF,Pollard AJ

    更新日期:2017-01-30 00:00:00

  • Bridging the gap between systems biology and medicine.

    abstract::Systems biology has matured considerably as a discipline over the last decade, yet some of the key challenges separating current research efforts in systems biology and clinically useful results are only now becoming apparent. As these gaps are better defined, the new discipline of systems medicine is emerging as a tr...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm88

    authors: Clermont G,Auffray C,Moreau Y,Rocke DM,Dalevi D,Dubhashi D,Marshall DR,Raasch P,Dehne F,Provero P,Tegner J,Aronow BJ,Langston MA,Benson M

    更新日期:2009-09-29 00:00:00

  • Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers.

    abstract:BACKGROUND:Hepatocellular carcinoma (HCC) is the one of the most common cancers and lethal diseases in the world. DNA methylation alteration is frequently observed in HCC and may play important roles in carcinogenesis and diagnosis. METHODS:Using the TCGA HCC dataset, we classified HCC patients into different methylat...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-018-0548-z

    authors: Cheng J,Wei D,Ji Y,Chen L,Yang L,Li G,Wu L,Hou T,Xie L,Ding G,Li H,Li Y

    更新日期:2018-05-30 00:00:00

  • Back to the family: a renewed approach to rare variant studies.

    abstract::A report on the 62nd Annual Meeting of the American Society of Human Genetics, San Francisco, California, USA, 6-10 November 2012. ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm398

    authors: Zielinski D,Gymrek M,Erlich Y

    更新日期:2012-12-19 00:00:00

  • Biomarker discovery in human cerebrospinal fluid: the need for integrative metabolome and proteome databases.

    abstract::The number of metabolites identified in human cerebrospinal fluid (CSF) has steadily increased over the past 5 years, and in this issue of Genome Medicine David Wishart and colleagues provide a comprehensive update that brings the number of metabolites listed in the CSF metabolome database to 476 compounds. There is n...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm338

    authors: Schwarz E,Torrey EF,Guest PC,Bahn S

    更新日期:2012-04-30 00:00:00

  • An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets.

    abstract::During COVID-19, diagnostic serological tools and vaccines have been developed. To inform control activities in a post-vaccine surveillance setting, we have developed an online "immuno-analytics" resource that combines epitope, sequence, protein and SARS-CoV-2 mutation analysis. SARS-CoV-2 spike and nucleocapsid prote...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00822-6

    authors: Ward D,Higgins M,Phelan JE,Hibberd ML,Campino S,Clark TG

    更新日期:2021-01-07 00:00:00

  • Moving pathogen genomics out of the lab and into the clinic: what will it take?

    abstract::Pathogen genomic analysis is a potentially transformative new approach to the clinical and public-health management of infectious diseases. Health systems investing in this technology will need to build infrastructure and develop policies that ensure genomic information can be generated, shared and acted upon in a tim...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0254-z

    authors: Luheshi LM,Raza S,Peacock SJ

    更新日期:2015-12-30 00:00:00